Our findings showed that JKZP improved hippocampal neuroplasticity, alleviated MCI symptoms, and slowed dementia progression by targeting S100A10/tPA‐mediated modulation of proBDNF/mBDNF homeostasis. The gene discussed is BDNF; the disease is dementia.